INZOLEN-Infusio E Infusionslösung

Recall | Medicines | 23/12/2022

The marketing authorisation holder informed its customers on December 23, 2022 that decreased dexpanthenol concentrations were detected during the ongoing stability programme. For this reason the batches mentioned below are being recalled. The medicinal product is authorised in Germany and placed on the market in Austria under the Austrian Act on the Import of Medicinal Products.

Name of the medicinal product INZOLEN-Infusio E Infusionslösung
Marketing authorisation number(s) Deutschland: 6072844.00.00
CIP code Deutschland: 842726 4
Marketing authorisation holder Dr. Franz Köhler Chemie GmbH
Batch number(s) 2105511, 2105512, 2105611
Expiry date 01/31/2023
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-4131

Further inquiry note